Exchange: NASDAQ·Updated 08:26 AM EDT

BLSM BlossomHill Therapeutics Inc..

$16.31
$0.15
(0.91%)
Pre-Market
Prev Close $16.46
EarningsNov 16
Mkt Cap$523.18M
Vol30.00

About BLSM

Blossomhill Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded on June 22, 2020 and is headquartered in San Diego, CA.
30

Bearish Sentiment

How do you feel about BLSM?

Advertisement|Remove ads.